Diane has spent over 35 years in the Pharma Industry, starting her career as a research pharmacologist at Smith Kline & French, before switching to Clinical Development in a CRO in 1988. She then spent 12 years taking roles of increasing responsibility and geographical scope, before moving to Pharma in 2000. During this she has led global clinical development programs, set up and managed a global in-house monitoring team, headed UCB’s Outsourcing Contracts & Strategic Partnering department, and is currently Head of Program Delivery, where she provides expertise and leadership of a global team to drive & oversee operational delivery of clinical programs of all phases across the portfolio, leadership of a Global Strategic Feasibility team where the increasing use of digital and AI technologies is supporting new approaches to site and country selection, as well as leadership of a Global Clinical Trial Patient Engagement team who support gathering patient insights before, during and after clinical trials, and patient recruitment activities. Enhancing clinical trial diversity is also a key responsibility within the Program Delivery team.
In addition, Diane has also represented UCB on the Integrated Leadership Team of TransCelerate since 2014.
Ivanna Rosendal is the VP of Digitalization at Ascendis Pharma, a behavioral economist and stand-up comedian. She has worked towards optimizing R&D in large and small biopharmaceutical companies the past 15 years. Now she focuses on leveraging technology to enhance the work of scientists, clinicians and medical teams, ensuring they can make a significant impact on patient outcomes. Through initiatives like my podcast, Lab to Lives, I aim to make life sciences more accessible and foster collaboration to drive meaningful change. Reach out to Ivanna on LinkedIn.
Joshua Cox has been honing his data management expertise in the drug development industry for nearly 20 years. After breaking into the industry and gaining exposure to diverse therapeutic areas and development approaches with a CRO, Joshua has focused the last 15-years in sponsor driven early phase oncology. He has enjoyed opportunities with bio-tech start-ups as well as established big pharma companies, each engagement adding valuable knowledge and experience to his skillset. Joshua has led the development of data management departments by conceiving and implementing fit for purpose and results-driven technologies and processes always with an eye toward innovation and efficiency. Now pursuing leadership opportunities outside the confines of traditional data management, Joshua is eager and excited to be a part of teams pursuing novel solutions to known challenges as well as employing cutting edge strategies and technologies to elevate the already high standards we expect and ultimately get the best medicines to the patients in need.
